KR920017655A - 상처의 치료를 촉진시키기 위한 약학 조성물 - Google Patents

상처의 치료를 촉진시키기 위한 약학 조성물 Download PDF

Info

Publication number
KR920017655A
KR920017655A KR1019920004144A KR920004144A KR920017655A KR 920017655 A KR920017655 A KR 920017655A KR 1019920004144 A KR1019920004144 A KR 1019920004144A KR 920004144 A KR920004144 A KR 920004144A KR 920017655 A KR920017655 A KR 920017655A
Authority
KR
South Korea
Prior art keywords
keto
prostaglandin compound
composition
dihydro
prostaglandin
Prior art date
Application number
KR1019920004144A
Other languages
English (en)
Other versions
KR100221370B1 (ko
Inventor
류지 우에노
Original Assignee
류지 우에노
가부시끼가이샤 알-테크 우에노
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13554827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR920017655(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 류지 우에노, 가부시끼가이샤 알-테크 우에노 filed Critical 류지 우에노
Publication of KR920017655A publication Critical patent/KR920017655A/ko
Application granted granted Critical
Publication of KR100221370B1 publication Critical patent/KR100221370B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

상처의 치료를 촉진시키기 위한 약학 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (16)

  1. 약학적으로 허용되는 담체, 희석제 또는 부형제와 함께 15-케토-프로스타글란딘 화합물을 포함하는, 상처의 치료를 촉진시키기 위한 약학 조성물.
  2. 제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 16-모노-또는 디-할로-15-케토-프로스타글란딘 화합물인 조성물.
  3. 제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-16-모노-또는 디-할로-15-케토-프로스타글란딘 화합물인 조성물.
  4. 제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-16-모노-또는 디-플루오로-15-케토-프로스타글란딘 화합물인 조성물.
  5. 제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-16, 16-디플루오로-15-케토-프로스타글란딘 화합물인 조성물.
  6. 제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 15-케토-20-알킬-프로스타글란딘 화합물인 조성물.
  7. 제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-15-케토-20-알킬-프로스타글란딘 화합물인 조성물.
  8. 제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-15-케토-20-에틸-프로스타글란딘 화합물인 조성물.
  9. 약학적으로 허용되는 담체, 희석제 또는 부형제와 함께 15-케토-프로스타글란딘 화합물을 포함하는, 각막의 상처의 치료를 촉진시키기 위한 약학 조성물.
  10. 제9항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 16-모노-또는 디-할로-15-케토-프로스타글란딘 화합물인 조성물.
  11. 제9항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-16-모노-또는 디 -할로-15-케토-프로스타글란딘 화합물인 조성물.
  12. 제9항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-16-모노-또는 디-플루오로-15-케토-프로스타글란딘 화합물인 조성물.
  13. 제9항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-16, 16-디플루오로-15-케토-프로스타글란딘 화합물인 조성물.
  14. 제9항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 15-케토-20-알킬-프로스타글란딘 화합물인 조성물.
  15. 제9항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-15-케토-20-알킬-프로스타글란딘 화합물인 조성물.
  16. 제9항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13, 14-디하이드로-15-케토-20-에틸-프로스타글란딘 화합물인 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019920004144A 1991-03-14 1992-03-13 상처의 치료를 촉진시키기 위한 약학 조성물 KR100221370B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7470291 1991-03-14
JP91-074702 1991-03-14

Publications (2)

Publication Number Publication Date
KR920017655A true KR920017655A (ko) 1992-10-21
KR100221370B1 KR100221370B1 (ko) 1999-09-15

Family

ID=13554827

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920004144A KR100221370B1 (ko) 1991-03-14 1992-03-13 상처의 치료를 촉진시키기 위한 약학 조성물

Country Status (12)

Country Link
US (1) US5252605A (ko)
EP (1) EP0503887B1 (ko)
JP (1) JP2515458B2 (ko)
KR (1) KR100221370B1 (ko)
AT (1) ATE141794T1 (ko)
AU (1) AU648877B2 (ko)
CA (1) CA2062653C (ko)
DE (1) DE69213057T2 (ko)
DK (1) DK0503887T3 (ko)
ES (1) ES2093774T3 (ko)
GR (1) GR3021117T3 (ko)
NZ (1) NZ241940A (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403867A (en) * 1992-02-07 1995-04-04 Kaken Pharmaceutical Co., Ltd. Preparation for treating wounds or hemorrhoids
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
DE69714698T2 (de) * 1996-06-10 2002-12-05 Sucampo Ag, Zug Endothelin-antagonisten
NZ336960A (en) * 1997-11-28 2001-02-23 R Tech Ueno Ltd Use of 15-keto-prostaglandin E compounds for the preparation of medicaments for use as endothelin antagonists
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
AR035242A1 (es) * 2001-05-18 2004-05-05 Sucampo Ag Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
WO2004004738A1 (ja) * 2002-07-02 2004-01-15 Wakamoto Pharmaceutical Co.,Ltd. 角結膜上皮細胞障害治療薬又は予防薬
US20050124699A1 (en) * 2002-07-02 2005-06-09 Wakamoto Pharmaceutical Co., Ltd. Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
EP1608378A1 (en) 2003-04-02 2005-12-28 Nexmed (Holdings), Inc. Prostaglandin compositions and their use for the treatment of vasospasm
ATE489955T1 (de) * 2005-03-04 2010-12-15 Sucampo Ag Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
NZ570190A (en) 2006-01-24 2011-03-31 Sucampo Ag Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
CA2639240A1 (en) * 2008-08-29 2010-02-28 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
US8513441B2 (en) 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
WO2010083597A1 (en) * 2009-01-22 2010-07-29 Apotex Pharmachem Inc. Methods of making lubiprostone and intermediates thereof
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8940794B2 (en) 2011-04-07 2015-01-27 Nexmed Holdings, Inc. Methods and compositions for treating Raynaud's disease
JP6957610B2 (ja) * 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.
JP2579193B2 (ja) * 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体

Also Published As

Publication number Publication date
CA2062653C (en) 2002-08-20
EP0503887A3 (en) 1993-01-13
DK0503887T3 (da) 1996-09-16
JP2515458B2 (ja) 1996-07-10
NZ241940A (en) 1997-07-27
AU1286192A (en) 1992-09-17
ES2093774T3 (es) 1997-01-01
DE69213057D1 (de) 1996-10-02
AU648877B2 (en) 1994-05-05
US5252605A (en) 1993-10-12
EP0503887A2 (en) 1992-09-16
JPH0570354A (ja) 1993-03-23
DE69213057T2 (de) 1997-01-09
EP0503887B1 (en) 1996-08-28
ATE141794T1 (de) 1996-09-15
CA2062653A1 (en) 1992-09-15
KR100221370B1 (ko) 1999-09-15
GR3021117T3 (en) 1996-12-31

Similar Documents

Publication Publication Date Title
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
KR920019342A (ko) 골질환 치료제
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
KR920000315A (ko) 모다피닐의 용도
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
ES2181165T3 (es) Uso de un peptido asociado a la latencia para la preparacion de un medicamento para aumentar la curacion de heridas.
KR890015742A (ko) 이병치료용 국소 제제
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
ATE117724T1 (de) Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
SE8600658D0 (sv) Novel composition of matter
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
ES2071143T3 (es) Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
KR910019621A (ko) 상승병용을 이용한 안고혈압 치료
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
KR910009271A (ko) 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료
SE7708176L (sv) Bensamidforeningar
NO873934L (no) Saarhelende serotoninantagonistisk forbindelse.
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
E601 Decision to refuse application
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110512

Year of fee payment: 13

EXPY Expiration of term